Alzheimer Disease Clinical Trials in Miami Lakes, Florida

4 studies are recruiting for alzheimer disease in Miami Lakes, Florida right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).

   The main purpose of this study is to determine if participants who previously took donanemab get clinical benefit when they receive annual doses. For each participant, the study will last up to 2.5 years and will include 6 visits.

   Stage

   Phase 3

   Ages

   55 and older

   Site

   Indago Research & Health Center, Inc, Miami Lakes, Florida

   Locations

   62 in total

   Run by

   Eli Lilly and Company

   See if you can join NCT07602582 on ClinicalTrials.gov

2. A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

   The purpose of this study is to evaluate the safety and efficacy of KarXT in adult participants with mild to severe Alzheimer's Disease (AD) with moderate to severe psychosis related to AD.

   Stage

   Phase 3

   Ages

   55 to 90

   Site

   Local Institution - 1209, Miami Lakes, Florida

   Locations

   296 in total

   Run by

   Karuna Therapeutics, Inc., a Bristol Myers Squibb company

   See if you can join NCT06585787 on ClinicalTrials.gov

3. DUVAX: A Phase 1 Alzheimer's Vaccine Study Targeting Amyloid-Beta and Tau

   This Phase 1 study will test the safety and immune response of the investigational vaccine DUVAX in healthy adults. Participants will be randomly assigned to receive either DUVAX or placebo by intramuscular injection. The study will evaluate how well the vaccine is tolerated and whether it produces…

   Stage

   Phase 1

   Ages

   40 to 65

   Site

   Palm Springs Community Health Center, Miami Lakes, Florida

   Run by

   Nuravax, Inc.

   See if you can join NCT07142278 on ClinicalTrials.gov

4. AV-1980R (Tau Vaccine) in Preclinical Alzheimer's Disease (TAURUS-1980)

   This is a Phase 1, multicenter, randomized, double-blind, placebo-controlled, multiple-dose-escalation study evaluating the safety, tolerability, and immunogenicity of AV-1980R, an investigational vaccine targeting pathological tau, in participants with preclinical Alzheimer's disease. Up to 48 cog…

   Stage

   Phase 1

   Ages

   65 to 80

   Site

   Palm Springs Community Health Center, Miami Lakes, Florida

   Locations

   6 in total

   Run by

   Institute for Molecular Medicine

   See if you can join NCT07158905 on ClinicalTrials.gov